Clinical Trials

Accrual Status
Limit to SWOG Trials

1040 Results

View
Closed
Phase
SWOG Clinical Trial Number
SWOG-772/773

Hodgkin's Disease: Remission Consolidation with Actinomycin D, Vinblastine, and Methotrexate (MOPP#3)
Activated
10-08-1969
Closed
11-09-1971
Closed
Phase
Accrual
1%
SWOG Clinical Trial Number
SWOG-229

Study of Dibromomannitol in Chronic Granulocytic Leukemia
Activated
08-06-1969
Closed
Phase
Accrual
58%
SWOG Clinical Trial Number
SWOG-434

Imidazole Carboxamide Dimethyl Triazene (NSC-45388) in Patients with Solid Tumors (Excluding Melanomas, Lymphomas, and Breast Cancer)
Activated
05-20-1969
Closed
06-24-1970
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
SWOG-431

Evaluation of Bis-Chlorethyl-nitrosourea (BCNU) in Multiple Myeloma
Research Committee(s)
Myeloma
Activated
04-16-1969
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
SWOG-227

Protocol for Phase II Trial of Actinomycin D & Vincristine in Lung Cancer
Activated
08-06-1968
Closed
08-21-1969
Closed
Phase
Accrual
4%
SWOG Clinical Trial Number
SWOG-717

Combination Drug (Cytoxan (NSC-26271), Vincristine (NSC-67574), Methotrexate (NSC-740) and 5-Fluorouracil (NSC-19893) Chemotherapy of Solid Tumor in Adults
Activated
07-29-1968
Closed
Phase
SWOG Clinical Trial Number
SWOG-756/759

Combination Chemotherapy in Advanced Hodgkin's Disease: Induction and Maintenance of Remission
Activated
09-29-1967
Closed
09-01-1973
Closed
Phase
Accrual
93%
SWOG Clinical Trial Number
SWOG-703

Combination for Cyclophosphamide (NSC-26271), Vincristine (NSC-67574) and 5-Fluorouracil (NSC-19893) in the Treatment of Advanced Breast Cancer
Activated
07-21-1967
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
SWOG-226

Phase II Protocol for Porfiromycin Solid Tumors
Activated
07-12-1967
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
SWOG-427

Cytosine Arabinoside (NSC-63878) in Acute Leukemia in Adults
Activated
07-01-1967
Closed
06-09-1969
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8264

Combination Chemotherapy with m-AMSA, Cis-Platinum and MGBG for Refractory Lymphoma
Activated
08-11-1962
Closed
03-16-1984
Closed
Phase
Accrual
6%
SWOG Clinical Trial Number
SWOG-200

Plan for a Cooperative Study in the Evaluation of the Effectiveness of Chemotherapeutic Agents in the Treatment of a Broadspectrum of Malignant Diseases in Adults
Activated
06-23-1961
Closed
Phase
SWOG Clinical Trial Number
SWOG-8570

Treatment of Brain Tumors With Intra-Arterial Cis-Platinum and BCNU
Closed
04-15-1987
Closed
Phase
SWOG Clinical Trial Number
SWOG-9001

Study of Alpha Interferon Plus 5-Fluorouracil in Patients with Advanced Renal Cell Carcinoma
Closed
07-15-1990
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8530

Efficacy of Prednisone in Refractory and Relapsing Multiple Myeloma and Measurement of Glucocorticoid Receptors
Closed
01-01-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8276

Evaluation of m-AMSA VP-16-213 and 5-Azacytidine Combination Chemotherapy in Adult Acute Non-Lymphocytic Leukemia
Closed
01-11-1985
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
SWOG-425/426

6-Mercaptopurine (NSC-755) and 6-Methylmercaptopurine Riboside (NSC-40774) Combination in the Treatment of Adult Acute Leukemia
Closed
11-04-1969
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8510

Intra-Arterial Cis-Platinum and Radiation Therapy in Primary Brain Tumors: A Phase II Randomized Study Comparing Sequential and Combined Treatments.
Closed
11-01-1988
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
SLA01

CHARACTERIZATION OF THE EXPRESSION OF IMMUNE CHECKPOINTS IN GASTRIC CANCER FROM LATIN AMERICAN COUNTRIES
Research Committee(s)
Gastrointestinal Cancer
Open
Phase
Accrual
0%
SWOG Clinical Trial Number
S2409

PRISM: PRecIsion in SCLC via a Multicohort Study: Randomized Phase II studies evaluating maintenance Durvalumab with or without Biomarker-Directed Therapy for Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Research Committee(s)
Lung Cancer